Keyword Suggestions
Results
Search
Current Library
All Libraries
Speakers
My Content
Sessions
Speakers
Entire Site
PROLibraries Home
Shopping Cart (
0 items
)
Account Login
Username
Password
Forgot Your Password?
Create an Account
Library Navigation
Home
Create Account
Browse Conferences
Browse All Sessions
Browse All Speakers
Browse Keywords
Online Specials
Customer Support
Browse Conferences
CRT 2007
Site Map
Cardiovascular Revascularization Therapies
Home
Browse Conferences
CRT 2007
Browse All Sessions
Abbott Vascular Response
Access Site Complications: With and Without Closure Devices
ACS Management in Latin America
ACUITY: Bivalirudin in ACS and Acute MI
Advanced CTO Techniques
Advanced CTO Techniques: Case Reviews
AGA Devices: PFO, PDA, ASD, Vascular Plug, and Muscular VSD
Alcohol Septal Ablations: Tips and Tricks
Animal Models to Study Vulnerable Plaque
Antegrade to Retrograde: An Evolving Technique
Anti-inflammatory Salicylic Acid Based Biodegradable DES
Approaches to Shorten Door-to-Balloon Time: Eindhoven Ambulance Triage Program
Are There Any Differences between TAXUS and CYPHER?
Arterial Access for Peripheral Interventions
Aspiration Devices are Helpful in Thrombus Management in Acute MI
Avoiding Complications during CAS and Management of Complications Once they Occur
Bifurcation Strategies and Techniques
Boston Scientific Corporation Response
Cardiac Complications: Hypotension, Shock and Stent Thrombosis
Cardiac MRI vs. CT: Striving for Optimal Images
Cardiomind Technology: Stent on a Wire
Carotid Lesion Assessment: Which Patients to Stent and Which to Operate - Lesion Related Treatment Strategies from an Interventionalist's Perspective
Carotid Stenting: Techniques and Credentialing
Case Presentations
Catheter Interentions in Acute Stroke
Catheters, Sheaths and Stents for Carotid Stenting
Challenges of Pharmacology Trials
Challenges with Dual Drugs on DES Platforms
Characterization and Molecular Detection of Atherothrombosis by Magnetic Resonance: Potential Tools for Individual Risk Assessment and Diagnostics
Cierra PFx System
Clinical and Angiographic Variables Related to Procedural Success: A Moving Target?
Clinical Experiences and Practical Limitations of OCT
Clinical Management Perspectives: Strategies for Optimal Staffing
Clinical Trial Design Challenges: Percutaneous vs. Surgical Trials
Clinical Trial Design for a New Technology: Limitations of Historical Controls
Clinical Trials of Emerging Drugs and Polymers
Clopidogrel Dosing and Timing in PCI and ACS: Loading and Chronic Therapy
Controversies in ESC and ACC/AHA Guidelines
Cord Blood Transplantation for Myogenesis: Do These Cells Have Greater Potential than Either Adult or Embryonic Stem Cells?
CoreValve
Coronary Endothelial Function: From Cell to Clinical Practice
Coronary Sinus Annuloplasty Devices
CTO Peripheral Recanalization
CTO: Interesting Cases
Current FDA Expectations Post Dec. 8
Current Status of Atherectomy Devices
Debate: Superior Strategies for AMI Management: No Need for Facilitated Pharmacology
Dedicated Bifurcated DES Programs
DES for In-stent Restenosis
DES for LM: The European Experience
DES for LM: The Korean Experience
DES for Patients with Diabetes
DES for SFA and Peripheral Arteries
DES for Unprotected LM
DES: Can We Prevent Subacute Stent Thrombosis in the Cath Lab?
Design Update of NMT for PFO Closure
Detection of Vasa Vasorum with IVUS
Devices and Preparations of Patients for ASD and PFO Closures
Did We Reach a Consensus on the Definition of Late Stent Thrombosis?
Discussion
Discussion: Can We Optimize the PCI and Reduce Complications of DES?
Discussion: What Should be the Next Clinical Trial after PROSPECT?
Does the Balance between Restenosis and Thrombosis Favor DES?
Drug Eluting Stents in AMI: A Proven Strategy?
Drug Eluting Stents: A Preemptive Treatment Choice for Vulerable Plaque
Dye Utilization During CTO Angioplasty: Minimizing, Monitoring and Managing Contrast Nephropathy
Early and Late Effects of Durable and Bioabsorbable Polymers
Edge-to-Edge Evalve Updates from the EVEREST Trials
Edwards' MOBIUS Leaflet Repaid System
Elast Eon-AorTech AVR
Emerging Drugs and Polymers: Lessons from Preclinical Trials
Emerging Excimer Laser Therapy in CLI
Endothelial Tubes Assembly, and Patterning of the Nervous and Vascular System
Endovascular Interventions for the Failing Access
Endovascular Management of Traumatic Thoracic Aortic Disruption
Endovascular Treatment of Aortic Dissection
Endovascular vs. Conventional Bypass for Patients with Tissue Loss
Endovenous Ablation: Patient Selection and Technical Tips
ERACI III: DES in Multiple Vessels vs. Surgery
Evolving Utility of Aspirin and Thienopyridines: New Insights into Anti-Platelet Resistance and Future Directions
External Radiation as Adjunct Therapy for Aortic Valvuloplasty
FDA Challenges to Determine Anti-Platelet Durations
FDA Expectations
Guide Catheter Selection, Backup Technique, Anchor Balloon and More
Guide Wire Techniques: Parallel Wire, Seesaw Technique and Multiple Wires
Guideline Modification for DES Use
Guideline Modifications for DES Use
Harmonization of the European and US Experience with the New Requirements
Harnessing Molecular Mechanisms Normally Involved in Collateral Remodeling to Enhance Collateral Development
High Risk PCI: What Lessons Have We Learned?
How Accurate are Late Loss Indices to Correlate Efficacy and Safety of DES
How Are We Doing with Minimizing Door-to-Balloon Time?
How Often Should Thrombectomy Devices Be Used During Primary Angioplasty?
How to Prepare Your Lab for Cell Therapy Research
How to Prevent Contrast Induced Nephropathy
How to Start a Stroke Program
Human Embryonic Stem Cells Have Documented Cardiac Potential
Hybrid Procedures for Suprarenal AAAs
Imaging of Small Vessels and Plaque Digestion
Immediate Response to the New Requirements of the FDA
Indications and Roles for Percutaneous Aortic Valve Replacement
Indications for Percutaneous Approach
Injectable Tissue Engineering: A New Strategy to Reload the Extracellular Matrix and Prevent Left Ventricular Remodeling and Dysfunction
Interesting Cases from Contemporary Practice in South America
Interventions for Chronic Total Occlusions
Intraplaque Lipid Detection with MRI: Clinical Results from the IVMRI Studies
Intravascular Ultrasound Profile Analysis of Ruptured Coronary Plaques
Introductory Comments
Is Clinical Imaging of Vulnerable Plaque Feasible?
Is Prolonged Dual Antiplatelet Therapy the Remedy for Late Stent Thrombosis?
Is the Recent Data on Increased Thrombosis and Death Reliable? How Does it Impact European Practice?
Is There a Role for Long Term Use of Clopidogrel for Primary and Secondary Prevention after CHARISMA?
Is There a Role for Vessel Preparation in the DES Era?
ISAR REACT 2: Abciximab in Patients with ACS Undergoing PCI
IVUS Guidance of CTO Recanalization
Keynote Address
Keynote Address: Overview of Critical Limb Ischemia: What is New in 2007
Keynote Lecture: A Unique Perspective on Percutaneous Valve Treatment: A Two Decade Odyssey from Balloons to Stent-Valves
Late-breaking Clinical Trials from South America
Late-breaking Clinical Trials: A Preview to i2 Summit 2007
Lessons from the OUS Experience
Low-Molecular Weight Heparins in ACS: New Insights from SYNERGY, STEEPLE and EXTRACT
Lp-PLA2 as a Potential Target for Plaque Stabilization
Lunch & Learn
Lunch & Learn Workshop: High Tech in the Cath Lab - Is that All You Have to Offer?
Lunch with the Wall Street Analysts, Industry and FDA
Manual Assist Technique: Results of the SafeGuard Manual Assist Technique Study
Materials and Design Concepts of Bioabsorbable Stents
Medical Therapy, Stenting or Surgery in the Elderly?
Minimally Invasive Distal Bypass
Mitral Surgical Repair vs. Percutaneous Valve Repair
Mitralign Suture-based Plication Annuloplasty
Multislice CT Guidance to CTO
Multislice CT Imaging of Vulerable Plaque
My Worst Complications
Myocardial Preservation Techniques
Myocor Coapsys System for Ventricular Remodeling with Annulus Reduction
Nanodelivery of Antirestenotic Drugs: FIM Results
New Devices for Stroke Prevention: Atrial Appendage Closure
New Drugs
New Imaging Guidance Technologies
New Integrated IVUS Systems in the Cath Lab
New Mechanisms to Understand the Vulnerable Plaque
New Polymers
New Strategies and Devices to Manage Cardiogenic Shock
Next Generation IVUS
Non-obstructive Plaques Should be Treated Medically
OASIS 5 and OASIS 6: Fondaparinux in ACS and AMI - The PCI Subsets
Optical Frequency Domain Imaging (OFDI)
Outcome of Complications of CTO
Overivew of Billing for Peripheral Procedures
Overview of Cryoplasty - From Therapy to Reality
Overview of Laser Technology and Clinical Applications of Laser
Overview of the Field: The Multiple Mechanisms by Which Stem Cells Might Improve Myocardial Performance
Overview of the Results of Randomized, Blinded Clinical Trials Employing Gene Therapy for Collaterogenesis
Paclitaxel Coated Balloon Catheter: Is that a Viable Substitute for DES?
Panel Discussion
Panel Discussion
Panel Discussion
Panel Discussion
Panel Discussion
Panel Discussion: Angiogenesis Trials for Chronic Myocardial Ischemia
Panel Discussion: Angiogenesis Trials Using Cell-based Strategies for AMI
Panel Discussion: FDA Requirements for New DES: Surrogate Endpoints
Panel Discussion: The Future of Stem Cell Therapy for Myogenesis in the Setting of Myocardial Scar
Panel Discussion: The Future of the Biodegradable Stent
Panel Discussion: What Should be the Upstream Therapy in ACS: Bivalirudin, Low Molecular Heparin, Fondaparinux llB/lllA?
Passive Ventricular Constraint and Surgical Ventricular Reconstruction
Percutaneous Aortic Valves: FDA Perspective
Percutaneous Mitral Replacement: Is it Feasible?
Percutaneous Mitral Valve Repair: Lessons from the EVEREST Trial
Peripheral Arterial Disease: Who Should Receive Intervention vs. Medical Therapy
Peripheral Intervention Surgery vs. Percutaneous Intervention
Permarketing Challenges
Pharmacology for Thrombus Management
Post MI Expression of VEGF-activating Zinc Finger Protein Increases Progenitor Cell Mobilization and Recruitment and Improves Outcome
Practical Issues Related to Pharmacology
Predictors of Success in Total Occlusions: Devices and Diagnostic Tools
Preparing for the AMI Patient in the Lab: Optimizing Door to Balloon Time
Procedural Complications II
Progenitor Cells: HEALING II and III
Provisional Stenting: Can FFR Help?
Questions & Discussion
Ranolazine: Inhibition of the Late Sodium Chanel for Chronic Angina
Regulatory Challenges for Biodegradable Stent Approval
Renal Artery Stenting Update: Is Renal Artery Bypass Dead?
Review of EVA-3S and SPACE: How Should they Influence Our Practice?
Review of Recent EVAR Trials
Review of the Randomized Trials and Early Results of CD34+ Cells for Intractable Myocardial Ischemia
Robotic Catheterization and Navigation in the Cath Lab
Role of Atherectomy Technologies for CLI
Role of DES for Restenosis Prevention for the SFA and Infrapopliteal Arteries
Salvage of Acute Limb Ischemia: What Can Be Done in the Cath Lab?
sanofi-aventis Response
Scoring Balloon
Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
Screening for Subclinical Atherosclerosis: A New Opportunity in Primary Prevention
Selection of a Balloon Valvuloplasty Group
Selection of a Surgical Control Group
Should All Diabetic Patients be Referred to Surgery?
Skeletal Myoblasts Bioheart Data - US and European Experience: Efficacy and Risks
Skeletal Myoblasts: The MAGIC Trial - Efficacy and Risks
St. Jude Premere PFO Closure System
Status of Primary PCI in the US: Lessons from NRMI
Stent Kissing Stent
Stereotaxis Navigation Imaging for CTO Recanalization
Study Population for Coronary Sinus Approaches
Study Population for Edge to Edge Repair
Subintimal Tracking and Re-entry Techniques
Surrogate Markers in DES: A Statistical View
Synopsis of the Last Circulatory Panel on DES
SYNTAX, Arts I and II: Do I Have Second Thoughts on Who Should Be Referred for CABG?
Tako Tsubo Syndrome
The "Georgetown Multidisciplinary Limb Salvage Formula"
The ASTAMI Trial
The BIOLIMUS Program Update
The Boston Scientific Petal Stent
The Cappella Sideguard Bifurcation Stent
The Cath Lab of 2010: A Glimpse into the Future
The CONOR Program Update
The Current Guidelines for Cartoid Stenting: What Are the Anatomical and Clinical Characteristics that Constitute High Risk?
The CYPHER Program Update
The Devax AXXESS and AXXESS PLUS Stent
The Dissection Reentry Concept Technique, Results and Practical Recommendations
The Guidant/Abbott Frontier Stent
The Igaki-Tamai Bioabsorbable Stent
The Impact of Arrhythmias in the Cath Lab Setting
The Israeli Parade of New Innovations for Interventional Cardiology I
The Israeli Parade of New Innovations for Interventional Cardiology II
The LEUVEN Trial
The New NIH Initiative on Stem Cells in the Treatment of Cardiovascular Disease: What are the Questions that Need to Be Addressed?
The Pathology of CTOs: Implications for Successful Wire and Device Crossing
The PROSPECT Trial: Design and Rationale for a Vulnerable Plaque Natural History Study
The PROVACEL Trial
The Radial Approach: Rational Techniques and Experience
The RESOLUTE Program
The REVA Medical Bioabsorbable Stent Program
The RF Approach to Treating Mitral Regurgitation: The T QuantumCor System
The Role of MRI in Endpoint Assessment
The Role of the Nuse and Tech in the Cath Lab in 2007: Striving for Excellence
The Role of the Vasa Vasorum in Vulnerable Plaque Progression: Primary or Secondary Factor?
The Self Expanding and Repositioning Sadra Technology
The Spatial Distribution of Myocardial Infarction: The Epidemiological Rational to Prevent MI
The State of the Field: What to Expect in the Next Five Years
The TAXUS Program Update
The Top Ten Events in Interventional Cardiology in 2006
The Tryton Side-branch Stent
The Y-med SideKick Stent
Trial Design for Dual Anti-Platelet Therapy for DES
Update on PFO Closures
Update on SVG Management
Use of Laser in Rescue AMI
Use of Progenitor Cells Derived from Adipose Tissue for Collateral Development
Vascular Profiling of Shear Stress and Vascular Remodeling in-vivo to Identify Early Stages of High-Risk Coronary Lesions
Ventricular Assist Devices for Chronic Heart Failure: Destination and Bridge to Recovery
Virtual Histology I: Concept and Validation
Virtual Histology II: US Clinical Experiences
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
Welcome & Introduction
What are the Experts Doing in 2007?
What is a High Surgical Risk?
What is in the Pipeline? New Drugs, New Polymers & New Stents
What is the Role for Laser in the Treatment of Infrainguinal Disease?
What Should the Appropriate Patient Follow-up Time Be?
When and How to Use Mechanical Devices
When and How to Use RF Technology
When Should Surgery Be Chosen as the First Line in Revascularization Strategy?
Which Patients Should We Refer for Carotid Endarterectomy? A Vascular Surgeon's Perspective
Who Should Not Get DES in 2007
Why Should We Monitor Platelet Inhibition?
Will the New Antiplatelet Agents in the Pipeline Replace Clopidogrel?
Xtent Technology: Programmable Length Drug Eluting Stents
Browse All Speakers
TBD
Alexandre Abizaid
Niv Ad
Cameron Akbari
David Allie
Yaron Almagor
John Ambrose
Gary Ansel
Vinjay Bahl
Donald Baim
Eric Bates
Peter Berger
Nelson Bernardo
Daniel Berrocal
Deepak Bhatt
Peter Block
Ashley Boam
Raoul Bonan
J.J.R.M. (Hans) Bonnier
Brett Bouma
Steven Boyce
Johannes Brachmann
Jeffrey Brinker
Ashesh Buch
Maurice Buchbinder
Silverio Cabellon
Diane Calabrese
Robert Califf
Gregory Campbell
Andrew Carter
Sidney Cohen
Howard Cohen
Howard Cooper
Paul Corso
Constantino Costantini
Michael Cowley
David Cox
Suzanne Crater
Frank Criado
Guilherme Dabus
Tony Das
Regina Deible
John Douglas
Stephen Epstein
Johanna Evans
Robert Falotico
Andrew Farb
Ted Feldman
Robert Fiorentino
Valentin Fuster
Robert Gallino
Gary Gershony
C. Michael Gibson
Frank Giordano
Donald Glower
Kenneth Gorski
Richard Gray
Eberhard Grube
Lee Guterman
Martial Hamon
Joshua Hare
Donald Harrington
Timothy Henry
Howard Hermann
Howard Herrmann
Richard Heuser
Marsha Holton
Michael Jaff
Stefan James
Stefan Janssens
Aamir Javaid
Aaron Kaplan
Osamu Katoh
Barry Katzen
Kenneth Kent
Spencer King
Nicolas Kipshidze
Neal Kleiman
Tian-Hai Koh
Jacques Koolen
Ran Kornowski
Mitchell Krucoff
Richard Kuntz
Michael Kutryk
Michael Laflamme
Robert Lager
Roger Laham
John Laird
James Laredo
Benjamin Lee
Martin Leon
Jonathan Leor
Amir Lerman
Frank Litvack
Julie Logan
Douglas Losordo
Ketil Lunde
Jacob Lustgarten
Michael Mack
William Maisel
Keith March
Paulina Margolis
Laura Mauri
Philippe Menasche
Erich Minar
Gary Mintz
Pedro Moreno
James Muller
Charles Murry
Morteza Naghavi
Richard Neville
Sharon-Lise Normand
Sean O'Donnell
Petros Okubagzi
Igor Palacios
Seung-Jung Park
Wesley Pedersen
Dahlia Plummer
Jeffrey Popma
Ramon Quesada
Steven Ramee
Evelyn Regar
Nicholaus Reifart
Nicolaus Reifart
Anthony Roberts
Keith Robinson
Alfredo Rodriguez
Kenneth Rosenfield
Stanton Rowe
Probal Roy
Carlos Ruiz
Wolf Sapirstein
Carol Satler
James Scanlon
Wolfgang Schaper
Dierk Scheinert
Daniel Schultz
Robert Schultz
Robert Schwartz
Patrick Serruys
Patric Serruys
Samin Sharma
John Shulze
Anton Sidawy
Horst Sievert
Sigmund Silber
Murthy Simhambhatla
Michael Simons
Charles Simonton
Michael Slack
Ronald Solar
Norman Stockbridge
Peter Stone
Bradley Strauss
S. Adam Strickberger
Krishan Sudhir
Julie Swain
James Tcheng
Etsuo Tsuchikane
Renu Virmani
Ron Waksman
Wm. Guy Weigold
Bonnie Weiner
Brant Weinstein
Mark Wholey
William Wijns
Josiah Wilcox
Robert Wilensky
Rick Wise
Elizabeth Wykpisz
Alan Yeung
Andrew Zalewski
Bram Zuckerman
Browse Keywords
stent
patients
clinical
heart
risk
pci
coronary
des
vascular
center
trial
death
months
post
vessel
device
cardiovascular
hospital
pts
days
lesions
medical
stents
study
lesion
plaque
patient
primary
follow
drug
wire
therapy
cto
balloon
acute
catheter
hill
late
treatment
time
thrombosis
stenting
cardiac
stroke
day
disease
distal
restenosis
circulation
results
Customer Support